📣 VC round data is live. Check it out!
- Public Comps
- BoneSupport
BoneSupport Valuation Multiples
Discover revenue and EBITDA valuation multiples for BoneSupport and similar public comparables like Heron Neutron Medical, Nakanishi, UFP Technologies, PROCEPT BioRobotics and more.
BoneSupport Overview
About BoneSupport
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).
Founded
1999
HQ

Employees
127
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialBoneSupport Financials
BoneSupport reported last 12-month revenue of $144M and EBITDA of $35M.
In the same LTM period, BoneSupport generated $133M in gross profit, $35M in EBITDA, and $23M in net income.
Revenue (LTM)
BoneSupport P&L
In the most recent fiscal year, BoneSupport reported revenue of $130M and EBITDA of $27M.
BoneSupport is profitable as of last fiscal year, with gross margin of 91%, EBITDA margin of 21%, and net margin of 12%.
Financial data powered by Morningstar, Inc.
BoneSupport Stock Performance
BoneSupport has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
BoneSupport's stock price is $24.87.
BoneSupport share price decreased by 0.8% in the last 30 days, and by 17.6% in the last year.
BoneSupport has an EPS (earnings per share) of $0.24.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | -0.8% | -0.8% | 16.8% | -17.6% | $0.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBoneSupport Valuation Multiples
BoneSupport trades at 11.0x EV/Revenue multiple, and 45.6x EV/EBITDA.
EV / Revenue (LTM)
BoneSupport Financial Valuation Multiples
As of June 2, 2026, BoneSupport has market cap of $2B and EV of $2B.
BoneSupport has a P/E ratio of 71.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BoneSupport Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


BoneSupport Margins & Growth Rates
BoneSupport grew revenue by 26% and EBITDA by 72% in the last fiscal year.
In the most recent fiscal year, BoneSupport reported gross margin of 91%, EBITDA margin of 21%, and net margin of 12%.
BoneSupport Margins
BoneSupport Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
BoneSupport Operational KPIs
BoneSupport's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.7M for the same period.
BoneSupport's Rule of 40 is 57% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BoneSupport's Rule of X is 100% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
BoneSupport Competitors
BoneSupport competitors include Heron Neutron Medical, Nakanishi, UFP Technologies, PROCEPT BioRobotics, Qingdao Baheal Medical, 4DMedical, Pulse Biosciences, Weigao Group, Beijing Balance Medical and Cofoe Medical.
Most BoneSupport public comparables operate across Medical Devices, DeepTech, HealthTech and BioTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4066.5x | - | (95.0x) | - | |||
| 2.7x | 2.6x | 10.9x | 10.5x | |||
| 3.0x | 2.9x | 15.1x | 14.5x | |||
| 4.6x | 4.1x | (28.2x) | (35.8x) | |||
| 1.7x | 1.6x | 13.3x | 13.2x | |||
| 370.0x | 312.6x | (86.1x) | (13.1x) | |||
| 4708.5x | 1081.6x | (32.7x) | (29.2x) | |||
| 5.9x | 5.6x | 16.9x | 17.4x | |||
This data is available for Pro users. Sign up to see all BoneSupport competitors and their valuation data. Start Free Trial | ||||||
BoneSupport VC Funding History
Before going public, BoneSupport raised $51M in total equity funding, across 2 rounds.
BoneSupport Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BoneSupport
| When was BoneSupport founded? | BoneSupport was founded in 1999. |
| Where is BoneSupport headquartered? | BoneSupport is headquartered in Sweden. |
| How many employees does BoneSupport have? | As of today, BoneSupport has over 127 employees. |
| Who is the CEO of BoneSupport? | BoneSupport's CEO is Emil Billback. |
| Is BoneSupport publicly listed? | Yes, BoneSupport is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of BoneSupport? | BoneSupport trades under BONEX ticker. |
| When did BoneSupport go public? | BoneSupport went public in 2017. |
| Who are competitors of BoneSupport? | BoneSupport main competitors include Heron Neutron Medical, Nakanishi, UFP Technologies, PROCEPT BioRobotics, Qingdao Baheal Medical, 4DMedical, Pulse Biosciences, Weigao Group, Beijing Balance Medical, Cofoe Medical. |
| What is the current market cap of BoneSupport? | BoneSupport's current market cap is $2B. |
| What is the current revenue of BoneSupport? | BoneSupport's last 12 months revenue is $144M. |
| What is the current revenue growth of BoneSupport? | BoneSupport revenue growth (NTM/LTM) is 28%. |
| What is the current EV/Revenue multiple of BoneSupport? | Current revenue multiple of BoneSupport is 11.0x. |
| What is the current EBITDA of BoneSupport? | BoneSupport's last 12 months EBITDA is $35M. |
| What is BoneSupport's EBITDA margin? | BoneSupport's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of BoneSupport? | Current EBITDA multiple of BoneSupport is 45.6x. |
| What is the current FCF of BoneSupport? | BoneSupport's last 12 months FCF is $26M. |
| What is BoneSupport's FCF margin? | BoneSupport's last 12 months FCF margin is 18%. |
| What is the current EV/FCF multiple of BoneSupport? | Current FCF multiple of BoneSupport is 60.8x. |
| How many companies BoneSupport has acquired to date? | BoneSupport hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies BoneSupport has invested to date? | BoneSupport hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to BoneSupport
Lists including BoneSupport
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.